01770naa a2200253 i 4500 acta78958 20230626061015.0 230626s2023 hu o 0|| hun d 2064-809X SZTE Egyetemi Kiadványok Repozitórium hun hun eng Plesz Szonja Bianka Oxitocin a szkizofrénia kezelésében [elektronikus dokumentum] : mítosz vagy csoda? / Plesz Szonja Bianka Szegedi Tudományegyetem Móra Ferenc Szakkollégiuma Szeged 2023 29-35 Móra Akadémia 12 Móra Akadémia : szakkollégiumi tanulmánykötet 12. 12 Schizophrenia is a complex mental disorder affecting 1% of the population. It is characterized by abnormal behavior, cognitive deficits, and hallucinations. The underlying pathological changes have not been completely discovered yet. However, it is hypothesized that the imbalance of the neurotransmitter systems like dopaminergic, serotonergic, glutamatergic, or cholinergic neural pathways are involved in the etiology of schizophrenia. There is growing evidence that the alteration of the oxytocinergic system also plays a role in its development. Moreover, several studies proved that the antipsychotic treatment combined with intranasal oxytocin could improve symptom severity. This minireview focuses on how the neurohormone oxytocin is related to schizophrenia. Orvos- és egészségtudomány Klinikai orvostan Oxitocin, Szkizofrénia - kezelés Móra Kárpát-medencei Interdiszciplináris Szakkollégiumi Konferencia (6.) (2022) (Szeged) http://acta.bibl.u-szeged.hu/78958/1/moraakademia_012_029-035.pdf Dokumentum-elérés